全球椎体成形术和椎体后凸成形术市场 – 行业趋势及 2029 年预测

 椎体成形术和椎体后凸成形术市场分析及规模

根据国际骨质疏松基金会的数据，骨质疏松症导致全球超过 890 万人骨折。椎体压缩性骨折是骨质疏松症的常见症状，每年在美国影响约 75 万人，其中大多数是女性。骨质疏松性椎体压缩性骨折可导致严重畸形和活动受限并发症。患有难以治愈的疼痛且保守治疗无效的患者可能会从椎体增强手术中受益。

Data Bridge Market Research 分析，椎体成形术和椎体后凸成形术市场在 2021 年的规模为 8.0495 亿美元，预计到 2029 年将达到 11.7127 亿美元，在 2022 年至 2029 年的预测期内的复合年增长率为 4.80%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外，Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、渠道分析、定价分析和监管框架。

椎体成形术和椎体后凸成形术市场范围和细分

市场定义

Verteoplasty is a minimally invasive spinal procedure in which bone cement is injected through a small hole in the skin into a fractured vertebra. Vertebroplasty relieves pain caused by compression fractures and stabilises the spine, thereby preventing further spinal dysfunction and improving quality of life. Kyphoplasty, is a type of spinal augmentation for compression fractures. This procedure relieves the pain caused by a vertebral fracture, stabilises the bone, and restores the height of the vertebral body, which has been reduced due to a compression fracture. Bone cement, also known as polymethyl-methacrylate, is injected into the fractured bone via a hollow needle during vertebroplasty.

In kyphoplasty, a balloon is inserted and inflated to expand the compressed vertebrae to their normal height, and then the space is filled with bone cement. Kyphosis is a modern spine surgery procedure used to stabilise vertebral compression fractures caused by osteoporosis, cancer, and other conditions.

Global Vertebroplasty and Kyphoplasty Market Dynamics

Drivers

• Launch of new products

Rising product launches, partnerships, and acquisitions by top market players are expected to boost segment growth. For instance, Medtronic plc launched its Kyphon Assist Directional Cannula in the United States in May 2020 to treat spinal compression fractures caused by osteoporosis, cancer, or benign lesions. As a result, these factors are expected to drive the growth of the kyphoplasty devices in the market.

• Surge in adoption of technologically advanced products

Medical device advancements have allowed for the reconstruction of various equipment, such as Crosstrees Medical, Inc.'s PVA Pod System, a novel bone cement delivery technology that does not require an implanted device in the spine. Medtronic's Khphon bone cement has been available with a new indication for sacral vertebral fracture since June 2018. The use of vertebroplasty and kyphoplasty equipment in the health care industry is increasing due to new applications of existing devices and the development of new devices. This equipment is used to perform various spine surgeries. This is driving the vertebroplasty and kyphoplasty market.

Opportunities

• Rising geriatric population will act as an opportunity

In recent years, the geriatric population has grown. According to the World Health Organization's October 2021 update, one in every six people worldwide is expected to be 60 or older by 2030. At this point, the proportion of the population aged 60 and up is expected to rise from 1 billion in 2020 to 1.4 billion. The world's population of people aged 60 and up is expected to double by 2050. (2.1 billion). The number of people aged 80 and up is expected to triple between 2020 and 2050, reaching 426 million. The most common fractures in osteoporosis patients are vertebral compression fractures, the geriatric population is more prone to osteoporosis. As a result, the market is expected to grow.

Restraints/Challenges

• High cost of treatment

Spinal surgeries are extremely expensive and in some cases, are not covered by insurance. This increases the burden on the patient and family, making it unaffordable for low-income people. In the United States, for instance, the cost of lumbar fusion spine surgery exceeds $45,000, which does not include the costs of imaging, diagnostics, medications, hospital care, and rehabilitation services, among other things.

This vertebroplasty and kyphoplasty market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vertebroplasty and kyphoplasty market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on the Vertebroplasty and Kyphoplasty Market

COVID-19 has spread throughout the world and has met the epidemiologic criteria for a pandemic. In this terrifying situation, standard medical practise was severely impacted, emphasising the treatment of coronavirus patients. The spine section was completely reorganised to reduce the rate of contamination of medical staff and patients during hospitalisation. The North American Spine Society (NASS) issued a guidance document in April 2020 that included clinical considerations and recommendations for surgeries and procedures classified as emergent, urgent, or elective.

Recent developments

• In April 2022, Nanox announced FDA approval for HealthOST Device, an AI software monitoring vertebral compression fractures and low bone density, which are frequently associated with osteoporosis.
• In August 2020, IZI Medical Products launched a osteo-site vertebral balloon ("Osteo-Site Balloon") for vertebral augmentation. It rounds out IZI's treatment options for vertebral compression fracture (VCF), which also include osteo-site vertebroplasty, osteo-site balloon kyphoplasty, blazer curved needle augmentation, and Kiva PEEK Implant-based augmentation.
• In August 2021, IZI Medical Products, LLC announced the official launch of Vertefix HV Cement. Vertefix HV is a novel technology for vertebroplasty and kyphoplasty procedures that meets the demand for real-time flow visualisation during cement injection. Product introductions are expected to boost market growth.

Global Vertebroplasty and Kyphoplasty Market Scope

椎体成形术和椎体后凸成形术市场根据产品和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场，并为用户提供有价值的市场概览和市场洞察，帮助他们做出战略决策，确定核心市场应用。

产品

• 椎体成形术
• 针
•  水泥搅拌
•  输送装置
• 椎体后凸成形术
• 针头和气球
• 水泥搅拌
• 输送装置

最终用途

• 医院
• 门诊手术中心

椎体成形术和椎体后凸成形术市场区域分析/见解

对椎体成形术和椎体后凸成形术市场进行了分析，并按国家、产品、最终用户和应用提供了市场规模洞察和趋势，如上所述。

椎体成形术和椎体后凸成形术市场报告涵盖的国家包括北美洲的美国、加拿大和墨西哥、欧洲的德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、欧洲其他地区、亚太地区 (APAC) 的中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、亚太地区 (APAC) 的其他地区、沙特阿拉伯、阿联酋、南非、埃及、以色列、中东和非洲 (MEA) 的其他地区、南美洲的巴西、阿根廷和南美洲其他地区。

由于医疗保健基础设施更好、人们和医疗保健行业利益相关者对现有技术的认识以及市场参与者在美国的高度集中等因素，北美在椎体成形术和椎体后凸成形术市场中占据主导地位。

预计亚太地区将在 2022 年至 2029 年的预测期内以最高增长率增长，因为老年人口不断增加以及对手术的接受度不断提高，这些因素都有助于市场增长。同样，诸如骨折固定先进方法的可用性、传统方法的局限性、椎体压缩性骨折发病率不断上升、骨质疏松症病例不断增加等因素也有助于推动市场增长。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

椎体成形术和椎体后凸成形术市场还为您提供了每个国家/地区资本设备医疗保健支出增长、椎体成形术和椎体后凸成形术市场不同类型产品的安装基数、使用生命线曲线的技术的影响以及医疗保健监管情景的变化及其对椎体成形术和椎体后凸成形术市场的影响的详细市场分析。数据适用于 2010-2020 年的历史时期。

竞争格局和椎体成形术和椎体后凸成形术市场份额分析

椎体成形术和椎体后凸成形术市场竞争格局提供了按竞争对手划分的详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对椎体成形术和椎体后凸成形术市场的关注有关。

椎体成形术和椎体后凸成形术市场的一些主要参与者包括：

• 美敦力（爱尔兰）
• Alphatec Spine, Inc（美国）
• 史赛克（美国）
• Merit Medical Systems（美国）
• Globus Medical（美国）
• IZI 医疗产品 (美国)
• ZAVATION（美国）
• RONTIS（瑞士）
• G21 Srl（意大利）
• SOMATEX Medical Technologies GmbH（德国）
• BPB MEDICA（意大利）
• Laurane Medical LLC（法国）
• Teknimed（法国）
• Benvenue Medical（美国）
• Spine Wave, Inc.（美国）
• MEDAID Inc.（新加坡）
• 康德乐 (美国)
• Joimax GmbH (德国)

SKU-55919